The synthesis, anti-inflammatory, analgesic and antimicrobial activities of ethyl 2-amino-4-alkyl-4,6-dihydropyrano[3,2c][2,1]benzothiazin-3-carboxylate 5,5-dioxides and triethylammonium 3-[(4-hydroxy-1-ethyl-2,2-dioxido-1h-2,1-benzothiazin-3-yl)alkyl]-1-


  • D. A. Lega National University of Pharmacy, Ukraine
  • N. I. Filimonova National University of Pharmacy, Ukraine
  • I. A. Zupanets National University of Pharmacy, Ukraine
  • S. K. Shebeko National University of Pharmacy, Ukraine
  • V. P. Chernykh National University of Pharmacy, Ukraine
  • L. A. Shemchuk National University of Pharmacy, Ukraine



2, 1-benzothiazine 2, 2-dioxide, aliphatic aldehydes, ethyl cyanoacetate, 2-amino-4H-pyran, triethylammonium, enolate, antimicrobial activity, anti-inflammatory activity, analgesic activity


The search for new groups of anti-inflammatory and analgesic drugs is a topical issue of the current medicinal chemistry. It is caused by numerous diseases that are accompanied by pain and inflammation, as well as by imperfection of the existing drugs aimed to provide treatment of these pathological conditions. Derivatives of 1H-2,1-benzothiazin-4(3H)-one 2,2-dioxide are promising chemicals to search and develop drugs with the pharmacological properties required. This heterocyclic system is structurally close to 2H-1,2-benzothiazin-4-one 1,1-dioxide, which is the core of the famous non-steroidal anti-inflammatory drugs related to the “oxicam” group. Moreover, derivatives of 1H-2,1-benzothiazin-4(3H)-one 2,2-dioxide are also considered to be promising structures for searching effective antimicrobial substances among them. The present article is devoted to the synthesis of new derivatives of 1H-2,1-benzothiazin-4(3H)-one 2,2-dioxide, namely ethyl 2-amino-4-alkyl-4,6-dihydropyrano[3,2-c][2,1]benzothiazin-3-carboxylate 5,5-dioxides and triethylammonium 3-[(4-hydroxy-1-ethyl-2,2-dioxido-1H-2,1-benzothiazin-3-yl)alkyl]-1-ethyl-1H-2,1-benzothiazin-5-olat 2,2-dioxides. Condensed 2-amino-4-alkyl-4H-pyran-3-carboxylates were synthesized via the three-component one-pot interaction of 1-ethyl-1H-2,1-benzothiazin-4(3H)-one 2,2-dioxide with ethyl cyanoacetate and aliphatic aldehydes. The abovementioned triethylammonium salts were obtained by the two component interaction of 1-ethyl-1H-2,1-benzothiazin-4(3H)-one 2,2-dioxide with aliphatic aldehydes in the presence of the equimolar amount of triethylamine. The study of the anti-inflammatory and analgesic activity has demonstrated high prospects of new effective drugs when searching among two classes of the compounds synthesized. The screening of the antimicrobial activity has shown that the compounds synthesized are the most active against the fungal strain of C. albicans.


Download data is not yet available.


  1. Mahmood Z., McNamara D. Alimentary Pharmacology & Therapeutics, 2003, Vol. 18, pp.31-37.
  2. Champion G. D., Feng P. H., Azuma T. et al. Drugs, 1997, Vol. 53, pp.6-19.
  3. Страчунский Л. С., Козлов С. Н. Нестероидные противовоспалительные средства: Методическое пособие, Смоленск, 2006.
  4. Green G. A. Clinical Cornerstone, 2001, Vol. 3, pp.50-59.
  5. Ukrainets I. V., Petrushova L. A., Dzyubenko S. P., Liu Y. Chem. Heterocycl. Compd. (N. Y., NY, U. S.), 2014, Vol. 50, pp.564-572.
  6. Pieroni M., Sabatini S., Massari S., Kaatz G. W., Cecchetti V., Tabarrini O. Med. Chem. Comm., 2012, Vol. 3, pp.1092-1097.
  7. Shafiq M., Zia-Ur-Rehman M., Khan I. U., Arshad M. N., Khan S. A. J. Chil. Chem. Soc., 2011, Vol. 56, pp.527-531.
  8. Lega D. A., Chernykh V. P., Shemchuk L. A., J. of Org. and Pharmac. Chem., 2016, Vol. 14, pp.6-16.
  9. Lega D. A., Gorobets N. Y., Chernykh V. P., Shishkina S. V., Shemchuk L. A. RSC Adv., 2016, Vol. 6, pp.16087-16099.
  10. Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 [Електронний ресурс]. Official J. of the Eur. Union, 2010 , Режим доступу до ресурсу: :32010L0063.
  11. Закон України «Про захист тварин від жорстокого поводження» [Електронний ресурс], 2006, Режим доступу до ресурсу: http://zakon5.
  12. Winter C. A., Risley E. A., Nuss G. W. Proc. Soc. Exp. Biol. Med., 1962, Vol. 111, pp.544-547.
  13. Доклинические исследования лекарственных средств: метод. рекоменд. / под ред. А. В. Стефанова, К: Авиценна, 2002, 528 с.
  14. Миронов А. Н., Бунатян Н. Д. Руководство по проведению доклинических исследований лекарственных средств. Ч. І, М.: Гриф и К, 2012, 944 с.
  15. Antônio M. A., Souza Brito A. R. M. J. Ethnopharmacol., 1998, Vol. 61, pp.215-228.
  16. Ravi V., Saleem T. M., Patel S. S., Raamamurthy J., Gauthaman K. Intern. J. of Applied Res. in Natural Products, 2009, Vol. 2, p.4.
  17. Державна фармакопея України / Державне підприємство «Науково-експертний фармакопейний центр», Х.: РІРЕГ, 2001, 556 с.
  18. Микробиология: Руководство к лабораторным занятиям. Учеб. пособие для студентов высших учебных заведений / И. Л. Дикий, И. И. Сидорчук, И. Ю. Холупяк, Х.: Изд-во НФаУ; Золотые страницы, 2002, C. 153.
  19. Компендіум on-line. [Електронний ресурс]. Режим доступу до ресурсу:
  20. Shemchuk L. A., Lega D. A., Redkin R. G., Chernykh V. P., Shishkin O. V., Shishkina S. V. Tetrahedron, 2014, Vol. 70, pp.8348-8353.




How to Cite

Lega, D. A.; Filimonova, N. I.; Zupanets, I. A.; Shebeko, S. K.; Chernykh, V. P.; Shemchuk, L. A. The Synthesis, Anti-Inflammatory, Analgesic and Antimicrobial Activities of Ethyl 2-Amino-4-Alkyl-4,6-dihydropyrano[3,2c][2,1]benzothiazin-3-Carboxylate 5,5-Dioxides and Triethylammonium 3-[(4-Hydroxy-1-Ethyl-2,2-Dioxido-1h-2,1-Benzothiazin-3-yl)alkyl]-1-. J. Org. Pharm. Chem. 2016, 14, 3-11.



Original Researches